|
Jul 30
|
NuCicer Raises $11.5M to Scale High-Protein Chickpeas and Accelerate Predictive Breeding Platform
|
|
Jul 30
|
Gear Up for Illumina (ILMN) Q2 Earnings: Wall Street Estimates for Key Metrics
|
|
Jul 30
|
Illumina enhances flagship assay to accelerate access to comprehensive tumor profiling
|
|
Jul 30
|
Illumina (ILMN) To Report Earnings Tomorrow: Here Is What To Expect
|
|
Jul 28
|
Illumina (ILMN) Stock Is Up, What You Need To Know
|
|
Jul 28
|
Non-Invasive Prenatal Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Eurofins Scientific, F. Hoffmann-La Roche, Invitae, Illumina, Natera, Centogene, and Qiagen
|
|
Jul 25
|
Why Cathie Wood Is Loading Up on This Hot Growth Stock (And Should You?)
|
|
Jul 24
|
Illumina (ILMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
|
Jul 24
|
Cathie Wood's Bold AI and Genomics Playbooks Revealed
|
|
Jul 24
|
Cathie Wood Pours Millions into Nvidia and Biotech, Dumps Rocket Lab
|
|
Jul 23
|
Clinical Next Generation Sequencing Market Trends and Forecasts Report 2025-2032 | Personalized Medicine and R&D Investments Propel Growth
|
|
Jul 18
|
Favorable Government Support Fuels Germany's Biotech Innovation and Commercialization: Market to Surpass USD 94 Billion by 2034 Led by QIAGEN, Thermo Fisher Scientific, Illumina and Roche
|
|
Jul 3
|
5 Must-Read Analyst Questions From Illumina’s Q1 Earnings Call
|
|
Jun 30
|
Proteomic Biomarker Analytics Market Forecast Report 2025: Proteomics Steps Up Where Genomics Falls Short
|
|
Jun 20
|
FTRE vs. ILMN: Which Stock Should Value Investors Buy Now?
|
|
Jun 20
|
1 of Wall Street’s Favorite Stock to Target This Week and 2 to Brush Off
|
|
Jun 18
|
3 Reasons ILMN is Risky and 1 Stock to Buy Instead
|
|
Jun 17
|
Incyte Stock Rises on QIAGEN Deal to Advance Blood Cancer Diagnostics
|
|
May 30
|
Illumina Introduces a New AI algorithm PromoterAI: Stock to Gain?
|
|
May 30
|
Illumina, Inc. (ILMN) Unveils AI Breakthrough for Rare Disease Diagnosis
|